Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations.
<h4>Introduction</h4>Germline BRCA1 or BRCA2 mutations account for 20-30% of familial clustering of breast cancer. The main indication for BRCA2 screening is currently the family history but the yield of mutations identified in patients selected this way is low.<h4>Methods</h4&g...
Main Authors: | Audrey Rouault, Guillaume Banneau, Gaëtan Macgrogan, Natalie Jones, Nabila Elarouci, Emmanuelle Barouk-Simonet, Laurence Venat, Isabelle Coupier, Eric Letouzé, Aurélien de Reyniès, Françoise Bonnet, Richard Iggo, Nicolas Sévenet, Michel Longy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284877/?tool=EBI |
Similar Items
-
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
by: Aurélie Kamoun, et al.
Published: (2016-04-01) -
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis
by: Bonnet Françoise, et al.
Published: (2012-11-01) -
An Interstitial Deletion at 10q26.2q26.3
by: Ivan Y. Iourov, et al.
Published: (2014-01-01) -
Terminal 4q deletion syndrome
by: C M Kuldeep, et al.
Published: (2012-01-01) -
5q deletion myelodysplastic syndrome
by: Preethi S Chari, et al.
Published: (2017-01-01)